SIHUAN PHARM(00460) Key Financial Indicators

Quotes

Detailed Quotes

Company Overview

Company Profile Company Executives

Financial Analysis

Main Composition Key Indicators Financial Statement

Multi-dimentional Analyses

Company Valuation Capital Tracking Short Selling Data

Company Overview More

Sihuan Pharmaceutical holding Group Co., Ltd. is a Hong Kong investment holding company engaged in pharmaceutical business. The company is mainly engaged in drug research and development, manufacturing and sales in China. Its products cover cardio-cerebrovascular, central nervous system, metabolism, tumor and anti-infection fields. Its products include cardio-cerebrovascular products such as Klingo, Agili and Odime, as well as non-cardio-cerebrovascular products such as Renao, metronidazole and roxatidine.

CEO： Fengsheng Che

Market： Hong Kong motherboard

Futu Hot List

HKUSCN

Trade HeatSearch HeatNews Heat

SymbolLatest price%Chg

Watchlist

YOY

Do not show

Hide blank lines

(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30(FY)2019/12/31

Per Share IndicaTor

Operating Cash Flow Per Share

2396.33% 0.0782 -82.95% 0.0285 -97.9% 0.0031 -22.78% 0.1672

Cash Flow Per Share

136.55% 0.0034 -130.3% -0.0644 -104.79% -0.0093 -29.13% 0.2126

Operating Income Per Share

98.83% 0.2425 -9.15% 0.3093 -38.88% 0.122 -3.38% 0.3405

Net Asset Per Share

25.48% 1.2515 1.82% 1.1536 -19.82% 0.9974 -25.02% 1.133

Basic Earning Per Share

358.82% 0.078 118.15% 0.059 107.02% 0.017 -265.82% -0.325

Diluted Earning Per Share

352.94% 0.077 118.15% 0.059 107.02% 0.017 -265.82% -0.325

Profitability

Gross Profit Ratio

3.2% 76.925% -2.27% 77.690% -9.43% 74.540% -2.52% 79.492%

Operating Profit Ratio

55.45% 46.453% 137.56% 31.942% 128.93% 29.884% -222.45% -85.032%

Net Profit Ratio

127.76% 31.156% 121.75% 20.773% 111.58% 13.680% -265.92% -95.509%

Earning Before Tax Ratio

49.98% 42.967% 136.37% 31.078% 127.58% 28.650% -223.89% -85.450%

ROE

296.69% 6.460% 121.17% 5.197% 109.25% 1.629% -282.82% -24.554%

ROA

288.69% 4.496% 119.64% 3.809% 108.39% 1.157% -277.87% -19.392%

Yield Quality

Operating Profit To Total Profits

3.65% 108.112% -- 102.779% -- 104.308% -- --

Tax To Total Profits

-37.76% 27.489% -- 28.601% -- 44.164% -- --

Operating Cash To Total Revenue

1155.29% 32.251% -81.23% 9.217% -96.57% 2.569% -20.08% 49.112%

Capital Structure

Debt Assets Ratio

-20.39% 25.347% 13.46% 23.729% 44.16% 31.838% 21.01% 20.914%

Equity Multipler

-4.45% 1.4534 8.46% 1.4193 14.52% 1.521 6.01% 1.3086

Debt Equity Ratio

-27.31% 33.954% 17.64% 31.112% 64.78% 46.710% 26.57% 26.445%

Current Assets To tatal Assets

-5.37% 50.099% -2.11% 49.097% 9.09% 52.940% 34.09% 50.155%

Non Current Assets To Total Assets

6.04% 49.901% 2.12% 50.903% -8.57% 47.060% -20.37% 49.845%

Current Liabilities To tatal Liabilities

-20.88% 71.894% -8.2% 78.931% 2.06% 90.862% 2.07% 85.986%

Non Current Liabilities To Total Liabilities

207.57% 28.106% 50.34% 21.069% -16.73% 9.138% -11.05% 14.014%

Solvency

Current Ratio

50.23% 2.7492 -6.01% 2.6213 -25.85% 1.83 8.57% 2.7889

Quick Ratio

47.72% 2.5322 -7.26% 2.4184 -26.53% 1.7141 7.1% 2.6078

Operating Profit To Current Liabilities

309.23% 0.3398 129.67% 0.3222 113.09% 0.083 -220.52% -1.0858

Operrating Cash Flow To Current Liabilities

3204.52% 0.2359 -85.18% 0.093 -98.45% 0.0071 -21.34% 0.6272

Share Equity Without Minority Interest To Total Liabilities

31.45% 2.7144 -18.74% 2.9692 -39.43% 2.065 -22.05% 3.6538

Operating Cash Flow To Total Liabilities

2514.89% 0.1696 -86.39% 0.0734 -98.42% 0.0065 -19.71% 0.5393

Operating Profit To Total Liabilities

223.8% 0.2443 127.24% 0.2543 113.36% 0.0755 -223.01% -0.9337

Operating Capacity

Inventory Turnover（T）

33.09% 0.8335 -24.28% 1.2485 -28.89% 0.6263 -17.22% 1.6488

Current Assets Turnover（T）

79.19% 0.2826 -15.36% 0.3998 -40.74% 0.1577 -12.65% 0.4723

Fixed Assets Turnover（T）

64.53% 0.6188 -15.31% 0.8771 -37.04% 0.3761 -5% 1.0357

Total Assets Turnover（T）

72.45% 0.1402 -2.48% 0.1983 -28.31% 0.0813 3.56% 0.2033

Growth Ability

Operating Revenue GR 3Y

268.15% 51.173% -20.08% -11.250% -286.21% -30.433% 20.06% -9.369%

Gross Income GR 3Y

268.51% 44.923% -197.14% -4.712% -161.62% -26.659% 107.65% 4.851%

Operating Profit GR 3Y

92.83% -4.956% 74.96% -53.893% 77.07% -69.074% -670.29% -215.200%

EBT GR 3Y

86.17% -9.850% 73.81% -56.199% 75.3% -71.213% -567.77% -214.614%

Net Profit GR 3Y

72.01% -23.422% 75.1% -65.771% 77.11% -83.691% -1140.85% -264.156%

Net Profit Attributable To The Parent Company GR 3Y

77.02% -19.089% 74.08% -67.691% 77.33% -83.083% -956.61% -261.194%

Total Assets GR 3Y

82.58% -1.337% -261.31% -5.095% -416.01% -7.673% -84.31% 3.159%

Share Equity Without Minority Interest GR 3Y

35.27% -14.760% -50% -17.803% -108.72% -22.801% -247.27% -11.869%

Equity GR 3Y

52.03% -9.821% -40.99% -13.211% -141.29% -20.473% -199.77% -9.370%

Total Liabilities GR 3Y

-10.74% 36.480% -69.27% 35.690% -46.79% 40.868% -8.2% 116.149%

Basic Earning Per Share GR 3Y

77.5% -18.750% 75.1% -67.935% 78.72% -83.333% -1446.28% -272.872%

Net Assets Per Share GR 3Y

35.91% -14.586% -69.84% -17.756% -653.35% -22.757% -157.29% -10.455%

Other Indicators

Currency Unit

HKDHKDHKDHKD

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%